Mindset Pharma Valuation

MSSTFDelisted Stock  USD 0.36  0.00  0.00%   
Mindset Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Mindset Pharma from analyzing the firm fundamentals such as Return On Equity of -2.43, current valuation of 19.22 M, and Profit Margin of (1.64) % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
0.36
Please note that Mindset Pharma's price fluctuation is very steady at this time. Calculation of the real value of Mindset Pharma is based on 3 months time horizon. Increasing Mindset Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Mindset otc stock is determined by what a typical buyer is willing to pay for full or partial control of Mindset Pharma. Since Mindset Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mindset OTC Stock. However, Mindset Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.36 Real  0.28 Hype  0.36 Naive  0.33
The real value of Mindset OTC Stock, also known as its intrinsic value, is the underlying worth of Mindset Pharma OTC Stock, which is reflected in its stock price. It is based on Mindset Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Mindset Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.28
Real Value
0.40
Upside
Estimating the potential upside or downside of Mindset Pharma helps investors to forecast how Mindset otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mindset Pharma more accurately as focusing exclusively on Mindset Pharma's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.190.300.41
Details
Hype
Prediction
LowEstimatedHigh
0.360.360.36
Details
Naive
Forecast
LowNext ValueHigh
0.330.330.33
Details

Mindset Pharma Total Value Analysis

Mindset Pharma is now anticipated to have takeover price of 19.22 M with market capitalization of 20.95 M, debt of 171.79 K, and cash on hands of 8.71 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Mindset Pharma fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
19.22 M
20.95 M
171.79 K
8.71 M

Mindset Pharma Investor Information

The company recorded a loss per share of 0.19. Mindset Pharma had not issued any dividends in recent years. Based on the key measurements obtained from Mindset Pharma's financial statements, Mindset Pharma is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.

Mindset Pharma Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Mindset Pharma has an asset utilization ratio of 39.98 percent. This implies that the OTC Stock is making $0.4 for each dollar of assets. An increasing asset utilization means that Mindset Pharma is more efficient with each dollar of assets it utilizes for everyday operations.

Mindset Pharma Ownership Allocation

Mindset Pharma maintains a total of 95.25 Million outstanding shares. Mindset Pharma secures 9.0 % of its outstanding shares held by insiders and 0.88 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Mindset Pharma Profitability Analysis

The company reported the revenue of 3.91 M. Net Loss for the year was (16.61 M) with profit before overhead, payroll, taxes, and interest of 3.91 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mindset Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mindset Pharma and how it compares across the competition.

About Mindset Pharma Valuation

The otc valuation mechanism determines Mindset Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Mindset Pharma. We calculate exposure to Mindset Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mindset Pharma's related companies.
Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. The company was founded in 2019 and is based in Toronto, Canada. Mindset Pharma is traded on OTC Exchange in the United States.

8 Steps to conduct Mindset Pharma's Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Mindset Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Mindset Pharma's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Mindset Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Mindset Pharma's revenue streams: Identify Mindset Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Mindset Pharma's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Mindset Pharma's growth potential: Evaluate Mindset Pharma's management, business model, and growth potential.
  • Determine Mindset Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Mindset Pharma's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

Mindset Pharma Growth Indicators

Investing in growth stocks can be very risky. If the company such as Mindset Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding94.6 M
Retained Earnings-28.7 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Mindset OTC Stock

If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios